Articles Tagged With: CA
-
IL-2 in HIV Infection: Raises CD4+ Cells, But at What Cost?
Actg 328 was a multicenter trial that studied HIV-1 infected adults without active AIDS-defining illnesses and with CD4+ lymphocyte counts between 50 and 350/uL. Patients were protease inhibitor (PI) and IL-2 naïve but may have received prior nucleoside analogue therapy.